Recombinant human keratinocyte growth factor-2 - Anhui Anke Biotechnology
Alternative Names: FGF-10 - Anhui Anke Biotechnology; rhKGF-2 - Anhui Anke BiotechnologyLatest Information Update: 28 Dec 2018
At a glance
- Originator Newsummit Biopharma
- Developer Anhui Anke Biotechnology
- Class Fibroblast growth factors
- Mechanism of Action Fibroblast growth factor stimulants; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Wounds
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for clinical-Phase-Unknown development in Wounds in China (Topical)
- 25 Nov 2015 Clinical trials in Wounds in China (Topical)